These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 27713238)

  • 1. Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.
    Cardoso S; Santos R; Correia S; Carvalho C; Zhu X; Lee HG; Casadesus G; Smith MA; Perry G; Moreira PI
    Pharmaceuticals (Basel); 2009 Dec; 2(3):250-286. PubMed ID: 27713238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders.
    Agarwal S; Yadav A; Chaturvedi RK
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1166-1177. PubMed ID: 27514452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact and Therapeutic Potential of PPARs in Alzheimer's Disease.
    Heneka MT; Reyes-Irisarri E; Hüll M; Kummer MP
    Curr Neuropharmacol; 2011 Dec; 9(4):643-50. PubMed ID: 22654722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration.
    Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB
    Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria: a therapeutic target in neurodegeneration.
    Moreira PI; Zhu X; Wang X; Lee HG; Nunomura A; Petersen RB; Perry G; Smith MA
    Biochim Biophys Acta; 2010 Jan; 1802(1):212-20. PubMed ID: 19853657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics.
    P P; Justin A; Ananda Kumar TD; Chinaswamy M; Kumar BRP
    ACS Chem Neurosci; 2021 Jul; 12(13):2261-2272. PubMed ID: 34125534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy.
    Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB
    Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR: a therapeutic target in Parkinson's disease.
    Chaturvedi RK; Beal MF
    J Neurochem; 2008 Jul; 106(2):506-18. PubMed ID: 18384649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation.
    Zolezzi JM; Santos MJ; Bastías-Candia S; Pinto C; Godoy JA; Inestrosa NC
    Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2046-2069. PubMed ID: 28220655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling.
    Wu Y; Chen M; Jiang J
    Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Mitophagy in Various Neurological Diseases as a Therapeutic Approach.
    Kaur S; Sharma N; Kumar V; Sharma D; Devi B; Kapil L; Singh C; Singh A
    Cell Mol Neurobiol; 2023 Jul; 43(5):1849-1865. PubMed ID: 36326951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin is a two-edged knife on the brain.
    Cardoso S; Correia S; Santos RX; Carvalho C; Santos MS; Oliveira CR; Perry G; Smith MA; Zhu X; Moreira PI
    J Alzheimers Dis; 2009; 18(3):483-507. PubMed ID: 19542630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
    Olesen MA; Villavicencio-Tejo F; Quintanilla RA
    Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease.
    Corona JC; Duchen MR
    Free Radic Biol Med; 2016 Nov; 100():153-163. PubMed ID: 27352979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.